Riskpilot← Back to searchSign inGet full accessMEDENSIT AB
ABActiveOrg 5569448474Järnvägsgatan 128Activities of holding companies · NACE 6421Est. 20130 employees
Revenue 2024
SEK 0
EBITDA margin
—
-71% vs 2023
Equity ratio
98.4%
Financial strength
Net profit 2024
SEK -8K
-119% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -9K | -71% |
| Net profit | SEK -8K | -119% |
| Total assets | SEK 745K | -1% |
| Equity | SEK 733K | -1% |
| Employees | 0 | — |
Legal name
MEDENSIT AB
Org number
5569448474
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
9 oktober 2013
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget ska bedriva konsulttjänster inom medicin och informationsteknologiska områden som systemutveckling, informationsanalys, systemanalys samt redovisningstjänster, samt grafisk design, samt övrig uppdrag förenlig med verksamheten.
Address
Järnvägsgatan 128
Email
arash78@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −3 | −2 | −3 | −5 | −9 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | −3 | −2 | −3 | −5 | −9 |
| Net financials | −7 | −1 | 0 | −2 | 1 |
| Profit before tax | 2 | 496 | −2 | 57 | −8 |
| Tax | −2 | −102 | — | −12 | — |
| Net profit | 0 | 394 | −2 | 45 | −8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 559 | 803 | 798 | 753 | 745 |
| Equity | 304 | 698 | 696 | 741 | 733 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 255 | 104 | 102 | 12 | 12 |
| Total debt | 255 | 104 | 102 | 12 | 12 |
EBITDA margin
-925900.0%
This company
15.8%
Market median
-5860227% vs market
20202024
Equity ratio
98.4%
This company
38.2%
Market median
+158% vs market
20202024
Return on equity
-1.2%
This company
18.4%
Market median
-107% vs market
20202024
Net profit margin
-845200.0%
This company
8.1%
Market median
-10434668% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AR Chief Executive Officer | Chief Executive Officer | 2025 |
| Former (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Deputy Board Member | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
MEDENSIT AB 
InsideMind ABBoard members of MEDENSIT AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alexandra Maria Sass | Chief Executive Officer | 0 companies |
| Arash Rezaei Anvari | Chief Executive Officer | 0 companies |
| Afshin Rezaei Anvari | Deputy Board Member | 0 companies |
| Masoumeh Mirkarim | Deputy Board Member | 0 companies |